http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 25 Jun 2025 17:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Press+Releases/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html <p align="justify" style="padding-left:0pt;">TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- <strong>Psyence Group Inc. (CSE: PSYG)</strong> (“<strong>Psyence</strong>” or the “<strong>Company</strong>”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “<strong>Offering</strong>”) of common shares in the capital of the Company (the “<strong>Common Shares</strong>”).</p> <p style="padding-left:0pt;">Pursuant to the Offering, the Company has raised gross proceeds of C$600,000 split into two tranches. Tranche 1 closed today, and the Company has issued an aggregate of 4,760,000 Common Shares at a price of http://www.streetinsider.com/Globe+Newswire/PSYENCE+GROUP+INC.+Announces+Update+on+Previously+Announced+Non-Brokered+Private+Placement+of+Common+Shares/24978120.html Wed, 25 Jun 2025 17:00:00 -0500 A.06822034 A.12119623 A.17150087 A.30032959 O.03270327 O.09898189 O.11217927 O.20026344 O.49223070 O.65258044 PBM PSYG PSYGF